| - GRCh37:
- Chr4:186066137
- GRCh38:
- Chr4:185144983
| SLC25A4 | R111S | not provided, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (Nov 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186068102
- GRCh38:
- Chr4:185146948
| SLC25A4 | D292H | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (May 7, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr4:186070600
- GRCh38:
- Chr4:185149446
| SLC25A4 | | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (Aug 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186071442
- GRCh38:
- Chr4:185150288
| SLC25A4 | | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (Aug 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186071354
- GRCh38:
- Chr4:185150200
| SLC25A4 | | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186071320
- GRCh38:
- Chr4:185150166
| SLC25A4 | | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (Aug 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186064462
- GRCh38:
- Chr4:185143308
| SLC25A4 | | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (Sep 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186069119
- GRCh38:
- Chr4:185147965
| SLC25A4 | | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Uncertain significance (Sep 29, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186070741
- GRCh38:
- Chr4:185149587
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Aug 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186068276
- GRCh38:
- Chr4:185147122
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Aug 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186066058
- GRCh38:
- Chr4:185144904
| SLC25A4 | | not provided, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186066044
- GRCh38:
- Chr4:185144890
| SLC25A4 | R80G | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | Likely pathogenic (Jun 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:16382201
- GRCh38:
- Chr1:16055706
| CLCNKB, LOC106501713 | C626Y, C456Y | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, not specified, not provided
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186071402
- GRCh38:
- Chr4:185150248
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Oct 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186071401
- GRCh38:
- Chr4:185150247
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Aug 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186070949
- GRCh38:
- Chr4:185149795
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Sep 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186070717
- GRCh38:
- Chr4:185149563
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Oct 18, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186069288
- GRCh38:
- Chr4:185148134
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Aug 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186068949
- GRCh38:
- Chr4:185147795
| SLC25A4 | | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 | Uncertain significance (Oct 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186067017
- GRCh38:
- Chr4:185145863
| SLC25A4 | R235G | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial disease | Pathogenic (Nov 15, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:186066045
- GRCh38:
- Chr4:185144891
| SLC25A4 | R80H | not provided, Inborn genetic diseases, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant
| Pathogenic (Jul 31, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:186067983
- GRCh38:
- Chr4:185146829
| SLC25A4 | T252M | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, not provided | Uncertain significance (Jun 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:78475230
- GRCh38:
- Chr13:77901095
| EDNRB, EDNRB-AS1 | S305N, S395N | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant, not specified, not provided, Hirschsprung disease, susceptibility to, 2, Waardenburg syndrome type 4A, Waardenburg syndrome type 2A
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |